ISIN | LU1626129990 |
---|---|
Valor Number | 37000647 |
Bloomberg Global ID | |
Fund Name | SYNCHRONY (LU) SWISS ALL CAPS (CHF) I |
Fund Provider |
Banque Cantonale de Genève
Genève, Switzerland Phone: +41 58 211 21 11 E-Mail: info@bcge.ch Web: www.bcge.ch |
Fund Provider | Banque Cantonale de Genève |
Representative in Switzerland |
GERIFONDS SA Lausanne Phone: +41 21 321 32 00 |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The objective of the sub-fund is long-term capital growth through investments in shares and other securities or participation rights issued by Swiss companies included in the SPI® Index. Companies are selected based on their intrinsic quality and manager's convictions, as well as economic cycles and, to the greatest extent possible, sustainable criteria. No guarantee can be given that the investment objective of the sub-fund will be achieved. |
Peculiarities |
Current Price * | 161.98 CHF | 28.08.2025 |
---|---|---|
Previous Price * | 161.73 CHF | 27.08.2025 |
52 Week High * | 172.67 CHF | 13.02.2025 |
52 Week Low * | 142.39 CHF | 09.04.2025 |
NAV * | 161.98 CHF | 28.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 50,564,742 | |
Unit/Share Assets *** | 32,094,762 | |
Trading Information SIX |
YTD Performance | +3.35% |
31.12.2024 - 28.08.2025
31.12.2024 28.08.2025 |
---|---|---|
1 month | -0.93% |
28.07.2025 - 28.08.2025
28.07.2025 28.08.2025 |
3 months | -2.51% |
28.05.2025 - 28.08.2025
28.05.2025 28.08.2025 |
6 months | -4.30% |
28.02.2025 - 28.08.2025
28.02.2025 28.08.2025 |
1 year | -3.17% |
28.08.2024 - 28.08.2025
28.08.2024 28.08.2025 |
2 years | +9.72% |
28.08.2023 - 28.08.2025
28.08.2023 28.08.2025 |
3 years | +11.30% |
29.08.2022 - 28.08.2025
29.08.2022 28.08.2025 |
5 years | +19.43% |
28.08.2020 - 28.08.2025
28.08.2020 28.08.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 8.89% | |
---|---|---|
Zurich Insurance Group AG | 8.82% | |
Nestle SA | 8.72% | |
Roche Holding AG | 8.63% | |
Geberit AG | 4.86% | |
Belimo Holding AG | 4.82% | |
Sika AG | 4.70% | |
Givaudan SA | 4.58% | |
ABB Ltd | 4.56% | |
Lonza Group Ltd | 4.46% | |
Last data update | 31.05.2025 |
TER | 1.03% |
---|---|
TER date | 30.06.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.02% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |